Today's clinicians are presented with an extensive range of oral antidiabetic drugs for type 2 diabetes. The main classes are heterogeneous in their modes of action, safety profiles and tolerability. These main classes include agents that stimulate insulin secretion (sulphonylureas ...
Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65:385- 411.Krentz AJ,Bailey C.Oral Antidiabetic Agents: Current role in Type 2 Diabetes Mellitus. Drugs . 2005Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs ...
Type 2 diabetes mellitus (T2DM) is globally recognized as a significant health concern, with diabetic foot (DF) identified as a severe long-term complication that can lead to tissue death or amputation. The discovery of the impact of mycobiota, a diverse group of multicellular eukaryotes in th...
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present —‘D’, either elevated blood glucose levels or a family history
Diabetic nephropathy is one of the most common complications in diabetes. It has been shown to be the leading cause of end-stage renal disease. However, due to their complex pathological mechanisms, effective therapeutic drugs other than angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin...
Type 2 diabetes mellitus (T2DM) is associated with functional deterioration of the salivary gland and dental pulp, related to oxidative stress. The aim was to integrate experimental and bioinformatic findings to analyze the cellular mechanism of melatonin (MEL) action in the human parotid gland and...
Until now, diabetes treatment drugs can only control blood glucose levels but cannot completely cure the disease. Diabetes mellitus may lead to chronic complications as the results of improper control. Various complications even happened at the first diagnosis of DM. 15–25 % of diabetic patients ...
Glucophage,metformin- an antidiabetic drug (trade name Glucophage) prescribed to treat type II diabetes sulfonylurea- antidiabetic consisting of any of several drugs that reduce the level of glucose in the blood; used to treat diabetes mellitus ...
Conclusion KD may improve lipid dysregulation in type 2 diabetic mice by downregulating hepatic PES1 expression.Introduction Type 2 diabetes mellitus (T2DM), characterized by insulin resistance (IR) and pancreatic β-cell dysfunction, is a heterogeneous metabolic disorder (Magliano et al. 2020). Compe...
This paper has become the seminal natural history study for CKD in type 2 diabetes. Article PubMed Google Scholar Bojestig, M., Arnqvist, H. J., Hermansson, G., Karlberg, B. E. & Ludvigsson, J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J....